SMTL ID : 7m2f.1

CDK2 with compound 14 inhibitor with carboxylate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

1 x YOS: [(1r,4r)-4-{4-[4-(5-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-3,6-dihydropyridin-1(2H)-yl}cyclohexyl]acetic acid(Non-covalent)

YOS.1: 17 residues within 4Å: Chain A: I.10, V.18, A.31, K.33, V.64, F.80, E.81, F.82, L.83, H.84, D.86, K.89, Q.131, N.132, L.134, A.144, D.145 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:V.18, A:A.31, A:V.64, A:F.80, A:F.80, A:K.89, A:L.134, A:D.145 Hydrogen bonds: A:L.83, A:L.83 Salt bridges: A:D.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tong, Y. et al., Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors. Acs Med.Chem.Lett. (2021)

Release Date

2021-07-07

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence